Paperpal Prime Logo

Metabolic Brain Disease : Impact Factor & More

eISSN: 1573-7365pISSN: 0885-7490

Key Metrics

CiteScore
5.8
Eigenfactor
0.005 - 0.01
Impact Factor
< 5
SJR
Q2Biochemistry
SNIP
1.02
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Metabolic Brain Disease

Metabolic Brain Disease Journal Specifications

Overview
Publisher SPRINGER/PLENUM PUBLISHERS
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1986
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Metabolic Brain Disease ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Metabolic Brain Disease

Role of the TLR4-NF-κB-FDX1 cuproptosis axis in mediating cognitive impairment associated with type 1 diabetes in children: an exploratory mechanistic study.
  • 6 Aug 2026
  • Metabolic brain disease
Polysaccharide-driven gut microbial metabolism in neurodegenerative brain diseases: from SCFAs and tryptophan catabolites to neuroinflammatory regulation.
  • 31 Jul 2026
  • Metabolic brain disease
Oleuropein regulates neuronal survival and Histone acetylation in Parkinson's disease: cellular and epigenetic insights.
  • 31 Jul 2026
  • Metabolic brain disease
Pentoxifylline targets TLR4/MyD88/NF-κB signaling to ameliorate neuroinflammation and metabolic dysfunction in a rat model of chronic hypoperfusion-induced vascular cognitive impairment.
  • 23 Jul 2026
  • Metabolic brain disease
From synaptic development to degeneration: a narrative review of small molecule strategies targeting alpha-synuclein in Parkinson's disease.
  • 23 Jul 2026
  • Metabolic brain disease
Metabolomic insights into migraine: mechanisms and biomarkers from in vivo and clinical studies.
  • 21 Jul 2026
  • Metabolic brain disease
Role of the TLR4-NF-κB-FDX1 cuproptosis axis in mediating cognitive impairment associated with type 1 diabetes in children: an exploratory mechanistic study.
  • 6 Aug 2026
  • Metabolic brain disease
Polysaccharide-driven gut microbial metabolism in neurodegenerative brain diseases: from SCFAs and tryptophan catabolites to neuroinflammatory regulation.
  • 31 Jul 2026
  • Metabolic brain disease
Oleuropein regulates neuronal survival and Histone acetylation in Parkinson's disease: cellular and epigenetic insights.
  • 31 Jul 2026
  • Metabolic brain disease
Pentoxifylline targets TLR4/MyD88/NF-κB signaling to ameliorate neuroinflammation and metabolic dysfunction in a rat model of chronic hypoperfusion-induced vascular cognitive impairment.
  • 23 Jul 2026
  • Metabolic brain disease
From synaptic development to degeneration: a narrative review of small molecule strategies targeting alpha-synuclein in Parkinson's disease.
  • 23 Jul 2026
  • Metabolic brain disease
Metabolomic insights into migraine: mechanisms and biomarkers from in vivo and clinical studies.
  • 21 Jul 2026
  • Metabolic brain disease

FAQs on Metabolic Brain Disease